2
Orphan Designations
5
FDA Approvals
4
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| COVID-19–associated multisystem inflammatory syndrome in children | reslizumab | Orphan Designation | - |
| bilirubin encephalopathy | reslizumab | Orphan Designation | - |
| hypereosinophilic syndrome | reslizumab | Orphan Designation | - |
| spinal muscular atrophy | reslizumab | Orphan Designation | - |